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Mediators pre-stored in neutrophil azurophilic granules
are central to the acute inflammatory response and tis-
sue degradation and damage through their proteolytic
activity. Different granule populations mobilize and
release their content via distinct and hierarchical mole-
cular mechanisms. The molecular mechanisms by which
mediators pre-stored in azurophilic granules are mobi-
lized and released to the extracellular space remain lar-
gely unknown. We used a number of complementary
techniques including; confocal laser scanning micro-
scopy, subcellular fractionation, flow cytometric ana-
lyses, Western blot analyses and electron microscopy to
examine the ultrastructural and molecular nature of
mediator release in neutrophil azurophilic granules. We
found that following IL-8 activation, neutrophil azuro-
philic granules undergo piecemeal degranulation (selec-
tive mediator release) leading to altered granule content.
Piecemeal degranulation of azurophilic granules is char-
acterized by budding of small secretory vesicles and
consequent reduction in granule density. Furthermore,
budding of small secretory vesicles and selective media-
tor mobilization and release from azurophilic granules is
associated with reduced localization of CD63, Hck and
b-arrestin-1 to granule membranes and also cell surface
upregulation of these molecules. Our study is first to
identify piecemeal degranulation as a potential underly-
ing mechanism of mediator release from neutrophil
azurophilic granules and supports the involvement of
CD63, Hck, and b-arrestin-1 in this process.
Author details
1From Department of Medicine, University of Calgary, Alberta, Canada.
2Harvard Thorndike Laboratory and Charles A. Dana Research Institute,
Departments of Medicine and Pathology, Beth Israel Deaconess Medical
Center, Harvard Medical School, Boston, MA 02215, USA.
3Department of
Immunology, University of Manitoba, Faculty of Medicine, Winnipeg,
Manitoba, Canada.
4The James Hogg iCAPTURE Centre, St. Paul’s Hospital,
Dept. of Medicine, University of British Columbia, Canada.
Published: 4 November 2010
doi:10.1186/1710-1492-6-S2-P20
Cite this article as: Mahmudi-Azer et al.: Molecular and morphological
characterization of piecemeal degranulation in human neutrophil
azurophilic granules. Allergy, Asthma & Clinical Immunology 2010 6(Suppl
2):P20.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
* Correspondence: sazer@shaw.ca
1From Department of Medicine, University of Calgary, Alberta, Canada
Full list of author information is available at the end of the article
Mahmudi-Azer et al. Allergy, Asthma & Clinical Immunology 2010, 6(Suppl 2):P20
http://www.aacijournal.com/content/6/S2/P20 ALLERGY, ASTHMA & CLINICAL 
IMMUNOLOGY
© 2010 Mahmudi-Azer et al; licensee BioMed Central Ltd.